FOLH1 and prostate carcinoma: While general PET imaging faces challenges such as motion artifacts and truncation errors, the use of 68Ga-labeled Prostate-Specific Membrane Antigen (PSMA) tracers for prostate cancer imaging introduces additional complexities.